MX2018010782A - Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. - Google Patents
Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica.Info
- Publication number
- MX2018010782A MX2018010782A MX2018010782A MX2018010782A MX2018010782A MX 2018010782 A MX2018010782 A MX 2018010782A MX 2018010782 A MX2018010782 A MX 2018010782A MX 2018010782 A MX2018010782 A MX 2018010782A MX 2018010782 A MX2018010782 A MX 2018010782A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- dosage regimen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un régimen de dosificación para la administración de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1- il]-N-ciclopropil-4-metilbenzamida o un derivado farmacéuticamente aceptable de la misma, específicamente en el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva crónica (AECOPD).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2016/050636 WO2017153702A1 (en) | 2016-03-08 | 2016-03-08 | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018010782A true MX2018010782A (es) | 2019-01-10 |
Family
ID=55586330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018010782A MX2018010782A (es) | 2016-03-08 | 2016-03-08 | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. |
Country Status (9)
Country | Link |
---|---|
US (2) | US10603306B2 (es) |
JP (1) | JP6741774B2 (es) |
KR (1) | KR20180118667A (es) |
AU (1) | AU2016397047B2 (es) |
BR (1) | BR112018067454A2 (es) |
CA (1) | CA3016488C (es) |
MX (1) | MX2018010782A (es) |
RU (1) | RU2713203C1 (es) |
WO (1) | WO2017153702A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018010782A (es) * | 2016-03-08 | 2019-01-10 | Mereo Biopharma 1 Ltd | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. |
GB201612238D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
HUE054266T2 (hu) | 2017-12-11 | 2021-08-30 | Mereo Biopharma 1 Ltd | 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus obstruktív tüdõbetegség akut megjelenésének megelõzésében |
HUE055425T2 (hu) * | 2017-12-11 | 2021-11-29 | Mereo Biopharma 1 Ltd | 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus elzáródásos tüdõbetegség akut fokozódásának kezelésében |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US6598603B1 (en) | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
PT2298743E (pt) | 2003-06-26 | 2012-12-04 | Novartis Ag | Inibidores de p38 quinase a base de heterociclo de 5 elementos |
TWI556829B (zh) | 2004-04-09 | 2016-11-11 | 艾伯維生物技術有限責任公司 | 用於治療TNFα相關失調症之多重可變劑量療法 |
GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
US20050277602A1 (en) | 2004-05-21 | 2005-12-15 | Grunstein Michael M | Methods employing agonists of P38 map kinase for the treatment of asthma |
JP2009526039A (ja) | 2006-02-10 | 2009-07-16 | ファイザー・プロダクツ・インク | ピリジノンピラゾール尿素およびピリミジノンピラゾール尿素誘導体 |
GB0603684D0 (en) | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
MA37455B1 (fr) * | 2012-03-20 | 2017-03-31 | Novartis Ag | Utilisation d'un dérivé de pyrazole dans le traitement d'exacerbations aigues d'une maladie pulmonaire obstructive chronique |
MX2018010782A (es) * | 2016-03-08 | 2019-01-10 | Mereo Biopharma 1 Ltd | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. |
RU2709509C1 (ru) * | 2016-03-08 | 2019-12-18 | Мерео Байофарма 1 Лимитед | Режим дозирования для лечения острых обострений воспалительных состояний |
-
2016
- 2016-03-08 MX MX2018010782A patent/MX2018010782A/es unknown
- 2016-03-08 RU RU2018132047A patent/RU2713203C1/ru active
- 2016-03-08 KR KR1020187026084A patent/KR20180118667A/ko not_active IP Right Cessation
- 2016-03-08 AU AU2016397047A patent/AU2016397047B2/en active Active
- 2016-03-08 BR BR112018067454A patent/BR112018067454A2/pt not_active Application Discontinuation
- 2016-03-08 CA CA3016488A patent/CA3016488C/en active Active
- 2016-03-08 JP JP2018547431A patent/JP6741774B2/ja active Active
- 2016-03-08 US US16/082,765 patent/US10603306B2/en active Active
- 2016-03-08 WO PCT/GB2016/050636 patent/WO2017153702A1/en active Application Filing
-
2020
- 2020-02-18 US US16/793,922 patent/US11129810B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP6741774B2 (ja) | 2020-08-19 |
CA3016488A1 (en) | 2017-09-14 |
WO2017153702A1 (en) | 2017-09-14 |
AU2016397047B2 (en) | 2022-04-07 |
BR112018067454A2 (pt) | 2019-01-15 |
US11129810B2 (en) | 2021-09-28 |
KR20180118667A (ko) | 2018-10-31 |
AU2016397047A1 (en) | 2018-09-06 |
US20190060279A1 (en) | 2019-02-28 |
CA3016488C (en) | 2023-04-11 |
US20200281896A1 (en) | 2020-09-10 |
JP2019507786A (ja) | 2019-03-22 |
RU2713203C1 (ru) | 2020-02-04 |
US10603306B2 (en) | 2020-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264210A (en) | High-dose cannabinoid dosage forms for oral administration | |
MX2018010782A (es) | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. | |
MX2022007989A (es) | Composiciones y metodos para tratar pterigion. | |
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
GB201500314D0 (en) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension | |
PH12014502107B1 (en) | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease | |
IL275484A (en) | W/O/W microemulsions for ophthalmic administration | |
AR100663A1 (es) | Formulaciones de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona | |
PH12016501841A1 (en) | Immunosuppressant formulation | |
MD3500241T2 (ro) | Terapie combinată pentru BPOC | |
ZA201708611B (en) | Pyrazole derivative, or pharmaceutically acceptable salt thereof | |
MX2018010781A (es) | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de condiciones inflamatorias. | |
HK1256017A1 (zh) | 用於治療癌症的口服給藥紫杉醇和p-gp抑制劑的治療組合 | |
MX2016010892A (es) | Agente para suprimir el progreso de o para mejorar la enfermedad renal cronica. | |
PH12016501975A1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
PT3650024T (pt) | Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência | |
HUE048002T2 (hu) | Többrétegû tabletta magnézium beadására | |
TN2017000003A1 (en) | Misoprostol dispersible tablet. | |
HRP20181123T1 (hr) | Spojevi 3,4-diamino-6-kloropirazin-2-karboksamida za liječenje bolesti posredovanih s enac | |
Nalkara | Peace at the Last: A Christian Theology of Last Things | |
AU2017904360A0 (en) | Dosage Regime for Treatment of Kidney Disease | |
AU2017902795A0 (en) | Dosage Regime for Treatment of Kidney Disease | |
AU2017902717A0 (en) | Dosage Regime for Treatment of Kidney Disease | |
MX2016017312A (es) | Composición farmacéutica de solifenacina en una tableta por comprension directa para su administración oral, para el tratamiento de alopatías relacionadas al mal funcionamiento de la vejiga. | |
ITUB20153076A1 (it) | Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. |